These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 37878112)

  • 1. Osteopontin: an essential regulatory protein in idiopathic pulmonary fibrosis.
    Zhu X; Ji J; Han X
    J Mol Histol; 2024 Feb; 55(1):1-13. PubMed ID: 37878112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelium-dependent profibrotic milieu in the pathogenesis of idiopathic pulmonary fibrosis: current status and future directions.
    Xu X; Dai H; Wang C
    Clin Respir J; 2016 Mar; 10(2):133-41. PubMed ID: 25047066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of OPN contributes to idiopathic pulmonary fibrosis and indicates a poor prognosis.
    Ji J; Zheng S; Liu Y; Xie T; Zhu X; Nie Y; Shen Y; Han X
    J Transl Med; 2023 Sep; 21(1):640. PubMed ID: 37726818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin silencing attenuates bleomycin-induced murine pulmonary fibrosis by regulating epithelial-mesenchymal transition.
    Hatipoglu OF; Uctepe E; Opoku G; Wake H; Ikemura K; Ohtsuki T; Inagaki J; Gunduz M; Gunduz E; Watanabe S; Nishinaka T; Takahashi H; Hirohata S
    Biomed Pharmacother; 2021 Jul; 139():111633. PubMed ID: 34243624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular matrix remodeling in idiopathic pulmonary fibrosis. It is the 'bed' that counts and not 'the sleepers'.
    Tomos IP; Tzouvelekis A; Aidinis V; Manali ED; Bouros E; Bouros D; Papiris SA
    Expert Rev Respir Med; 2017 Apr; 11(4):299-309. PubMed ID: 28274188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial⁻Mesenchymal Transition in the Pathogenesis of Idiopathic Pulmonary Fibrosis.
    Salton F; Volpe MC; Confalonieri M
    Medicina (Kaunas); 2019 Mar; 55(4):. PubMed ID: 30925805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three dimensional fibrotic extracellular matrix directs microenvironment fiber remodeling by fibroblasts.
    Nizamoglu M; Alleblas F; Koster T; Borghuis T; Vonk JM; Thomas MJ; White ES; Watson CK; Timens W; El Kasmi KC; Melgert BN; Heijink IH; Burgess JK
    Acta Biomater; 2024 Mar; 177():118-131. PubMed ID: 38350556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis.
    Pardo A; Selman M
    Ann Am Thorac Soc; 2016 Dec; 13 Suppl 5():S417-S421. PubMed ID: 28005427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation and immunity in IPF pathogenesis and treatment.
    Heukels P; Moor CC; von der Thüsen JH; Wijsenbeek MS; Kool M
    Respir Med; 2019 Feb; 147():79-91. PubMed ID: 30704705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Klotho antagonizes pulmonary fibrosis through suppressing pulmonary fibroblasts activation, migration, and extracellular matrix production: a therapeutic implication for idiopathic pulmonary fibrosis.
    Huang Q; Chen Y; Shen S; Wang Y; Liu L; Wu S; Xu W; Zhao W; Lin M; Wu J
    Aging (Albany NY); 2020 Apr; 12(7):5812-5831. PubMed ID: 32244228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblastic foci, covered with alveolar epithelia exhibiting epithelial-mesenchymal transition, destroy alveolar septa by disrupting blood flow in idiopathic pulmonary fibrosis.
    Yamaguchi M; Hirai S; Tanaka Y; Sumi T; Miyajima M; Mishina T; Yamada G; Otsuka M; Hasegawa T; Kojima T; Niki T; Watanabe A; Takahashi H; Sakuma Y
    Lab Invest; 2017 Mar; 97(3):232-242. PubMed ID: 27941755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Immune Cells in the Initiation and Progression of Pulmonary Fibrosis.
    Soumyakrishnan S; Ayariga JA; Sreepriya M; Sudhandiran G
    Crit Rev Immunol; 2022; 42(5):21-41. PubMed ID: 37075017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BDNF/TrkB axis activation promotes epithelial-mesenchymal transition in idiopathic pulmonary fibrosis.
    Cherubini E; Mariotta S; Scozzi D; Mancini R; Osman G; D'Ascanio M; Bruno P; Cardillo G; Ricci A
    J Transl Med; 2017 Sep; 15(1):196. PubMed ID: 28938915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How the Pathological Microenvironment Affects the Behavior of Mesenchymal Stem Cells in the Idiopathic Pulmonary Fibrosis.
    Bonifazi M; Di Vincenzo M; Caffarini M; Mei F; Salati M; Zuccatosta L; Refai M; Mattioli-Belmonte M; Gasparini S; Orciani M
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis.
    Craig VJ; Zhang L; Hagood JS; Owen CA
    Am J Respir Cell Mol Biol; 2015 Nov; 53(5):585-600. PubMed ID: 26121236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Cellular Senescence Is Independent from Profibrotic Fibroblast-Deposited ECM.
    Blokland KEC; Habibie H; Borghuis T; Teitsma GJ; Schuliga M; Melgert BN; Knight DA; Brandsma CA; Pouwels SD; Burgess JK
    Cells; 2021 Jun; 10(7):. PubMed ID: 34209854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bidirectional epithelial-mesenchymal crosstalk provides self-sustaining profibrotic signals in pulmonary fibrosis.
    Yao L; Zhou Y; Li J; Wickens L; Conforti F; Rattu A; Ibrahim FM; Alzetani A; Marshall BG; Fletcher SV; Hancock D; Wallis T; Downward J; Ewing RM; Richeldi L; Skipp P; Davies DE; Jones MG; Wang Y
    J Biol Chem; 2021 Sep; 297(3):101096. PubMed ID: 34418430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets.
    Hewlett JC; Kropski JA; Blackwell TS
    Matrix Biol; 2018 Oct; 71-72():112-127. PubMed ID: 29625182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dicer1 Deficiency in the Idiopathic Pulmonary Fibrosis Fibroblastic Focus Promotes Fibrosis by Suppressing MicroRNA Biogenesis.
    Herrera J; Beisang DJ; Peterson M; Forster C; Gilbertsen A; Benyumov A; Smith K; Korenczuk CE; Barocas VH; Guenther K; Hite R; Zhang L; Henke CA; Bitterman PB
    Am J Respir Crit Care Med; 2018 Aug; 198(4):486-496. PubMed ID: 29579397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of MicroRNAs in Signaling Pathways Associated with the Pathogenesis of Idiopathic Pulmonary Fibrosis: A Focus on Epithelial-Mesenchymal Transition.
    Cadena-Suárez AR; Hernández-Hernández HA; Alvarado-Vásquez N; Rangel-Escareño C; Sommer B; Negrete-García MC
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.